• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number VBJR071002A
Device Problem Device Contamination with Body Fluid (2317)
Patient Problems Bacterial Infection (1735); Stenosis (2263)
Event Date 12/09/2018
Event Type  Injury  
Manufacturer Narrative
Review of the manufacturing records could not be performed as no lot number information was provided.The device was not returned.Consequently, a direct product analysis was not possible.Additional information about this event could not be obtained.As a result, no further investigation is possible.All information has been placed on file for use in tracking and trending.A response letter was not requested.
 
Event Description
The following was reported to gore by the implanting surgeon: the patient presented with stenosis in the sfa.A gore® viabahn® endoprosthesis was implanted (b)(6) 2018.The patient reported pain (b)(6) 2018 in the area of the implant.Computed tomography angiography (cta) on (b)(6) 2018 revealed the device was performing as expected.Another cta taken (b)(6) 2018 revealed fluid around the gore® viabahn® endoprosthesis.The device was explanted (b)(6) 2018.The doctor reported to gore the fluid around the device was cx positive from perivascular fluid staphylococcus lugdunensis (coagulase-negative, gram-positive bacterium that can be isolated as a component of normal skin flora in humans).
 
Manufacturer Narrative
Corrected date.
 
Manufacturer Narrative
Additional manufacturer narrative: refer to medwatch report#: 2017233-2019-00010 for other gore® viabahn® endoprosthesis involved with this event.
 
Event Description
Additional information received indicates that two gore® viabahn® endoprosthesis were implanted on (b)(6) 2018 and explanted on (b)(6) 2018) due to the reported infection.
 
Manufacturer Narrative
Additional manufacturer narrative: review of the manufacturing records indicated the lots met pre-release specifications.Additional information about this event could not be obtained.As a result, no further investigation is possible.All information has been placed on file for use in tracking and trending.
 
Manufacturer Narrative
Additional manufacturer narrative: h4.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8196533
MDR Text Key131408959
Report Number2017233-2018-00798
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 01/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/26/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/29/2021
Device Catalogue NumberVBJR071002A
Device Lot Number18596984
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
-
-